Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

Sun Yat-sen University

Status: Completed

Conditions: Locally Advanced Cervical Carcinoma; Uterine Cervical Neoplasms; Surgery; Therapy

Treatments: Procedure: surgery

Study type: Observational

Funder types: Other

Identifiers

NCT06897306

SYSKY-2025-057-01

Details and patient eligibility

About

This study aims to collect data of patients with Gastric-type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of Gastric-type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric-type Endocervical Adenocarcinoma.

Full description

This study aims to collect data of patients with Gastric - type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of patients with Gastric - type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric - type Endocervical Adenocarcinoma.

Study subjects: Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER*Stat 8.4.2 software. The search scope was the "SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019)" database, and the screening criteria included "Site and Morphology, Analytic Behavior Recode = Malignant" and "Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix". Patients with cervical Gastric - type Endocervical Adenocarcinoma were selected from the database.

Outcome measures: Overall survival (OS): The time from diagnosis to death of the patient.

Enrollment: 317 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER*Stat 8.4.2 software. The search scope was the "SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019)" database. The screening criteria included "Site and Morphology, Analytic Behavior Recode = Malignant" and "Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix". Patients with Gastric - type Endocervical Adenocarcinoma in the database were selected.

Exclusion criteria

• Patients with a survival time of 0 or unknown.